Latest Dividend Declarations News

Origin Energy has announced a fully franked dividend of AUD 0.30 per share for the six months ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Oneview Healthcare PLC reported a 21% increase in total revenue to €12 million for the year ended 31 December 2025, driven by growth in recurring revenue and customer expansion. Despite this, the company’s loss after tax widened to €12.6 million, reflecting ongoing investment and cost pressures.

Northern Star Resources has reported a robust half-year result with a 41% jump in net profit, driven by soaring gold prices despite operational setbacks. The company also declared a fully franked interim dividend of 25 cents per share.

Insurance Australia Group Limited has announced a quarterly dividend of AUD 1.6241 per security for its Capital Notes, payable mid-March 2026, reflecting a steady 6.5141% annualised distribution rate.

Insurance Australia Group’s half year net profit fell 35% to $505 million, weighed down by natural peril claims and integration costs from its RACQI acquisition. Despite this, the insurer maintains its full-year guidance and announces a $200 million share buy-back.

Oakridge International Limited has reported a striking turnaround in its half-year results, posting a profit after tax of $172,239 against a prior loss, driven by strong sales and product innovation in healthcare technology.

humm Group Limited has posted a statutory profit after tax of $13.9 million for the half-year ended 31 December 2025, marking a 49% decline from the previous year, driven by increased credit losses and legal costs. Despite challenges, the company declared a fully franked interim dividend of 1.5 cents per share.

Bravura Solutions reports robust half-year growth with nearly 10% revenue increase, a fresh leadership appointment, and strategic expansion into the UK pensions market.

Bravura Solutions reported a solid 9.8% increase in underlying revenue for the half-year ending December 2025, despite the absence of prior non-recurring licence sale income. The company also announced a new CEO appointment and declared both interim and special dividends.

Kelly Partners Group Holdings Limited reported a 17% rise in revenue for the half-year to December 2025, while statutory profit fell 15.5% due to acquisition costs and higher amortisation. Underlying earnings showed solid growth, reflecting the firm's core business strength.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.

Commonwealth Bank of Australia reported a 5% rise in net profit for the half-year ended December 2025, balancing lending growth with margin pressures and increased technology investment.